Traws Pharma closes stock purchase agreement
Traws Pharma entered into a stock purchase agreement with Roth Principal Investments as of Oct. 23, 2026, defining terms for future capital market transactions and compliance procedures.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed